Skip to main content
Year archive

GLENMARK PHARMACEUTICALS LIMITED — 2018 filings

All 40 regulatory filings released by GLENMARK PHARMACEUTICALS LIMITED (4G8B) in 2018, sourced directly from the official regulator.

40 Filings
2018 Period
2018 filings (40)
Filing Released Lang
General Announcement::Glenmark Pharmaceuticals Announces Entry into Branded Dermatology Segment in the United States
Regulatory Filings
2018-12-19 English
General Announcement::Glenmark Pharmaceuticals receives ANDA approval for Fluocinolone Acetonide Oil, 0.01% (Ear Drops)
Regulatory Filings
2018-12-18 English
General Announcement::Glenmark Pharmaceuticals Announces New Data on GBR 1302, a HER2xCD3 Bispecific Antibody
Regulatory Filings
2018-12-17 English
General Announcement::Glenmark Pharmaceuticals receives ANDA approval for Atovaquone Oral Suspension USP, 750 mg/5 mL
Regulatory Filings
2018-11-22 English
General Announcement::Glenmark Pharmaceuticals receives ANDA approval for Azelaic Acid Gel, 15%
Regulatory Filings
2018-11-20 English
General Announcement::GPL Announces New Data Presentations on Ryaltris at the ACAAI Annual Scientific Meeting 2018
Regulatory Filings
2018-11-16 English
General Announcement::Glenmark Pharmaceuticals receives ANDA approval for Teriflunomide Tablets, 7 mg and 14 mg
Regulatory Filings
2018-11-16 English
General Announcement::Glenmark launches globally-renowned hair growth formula Nourkrin in Russia
Regulatory Filings
2018-11-01 English
General Announcement::Glenmark receives ANDA approval for Fluocinolone Acetonide Topical Oil, 0.01% (Scalp Oil)
Regulatory Filings
2018-10-30 English
General Announcement::Glenmark receives ANDA approval for Fluocinolone Acetonide Topical Oil, 0.01% (Body Oil)
Regulatory Filings
2018-10-26 English
General Announcement::Data on Glenmark Pharmaceuticals GBR 830
Regulatory Filings
2018-10-19 English
General Announcement::Glenmark Pharmaceuticals receives ANDA approval for Hydrocortisone Valerate Cream USP, 0.2%
Regulatory Filings
2018-10-15 English
General Announcement::ANNOUNCEMENT OF SETTLEMENT OF THE REPURCHASE EQUITY-LINKED SECURITIES DUE 2022
Capital/Financing Update
2018-10-09 English
General Announcement::Annual Report 2017-18
Regulatory Filings
2018-10-03 English
General Announcement::Update on intimation regarding the Orthopaedic Business
Regulatory Filings
2018-10-01 English
General Announcement::U.S.$200,000,000 2.00 PER CENT. RESETTABLE ONWARD STARTING EQUITY-LINKED SECURITIES DUE 2022
Capital/Financing Update
2018-09-28 English
General Announcement::Outcome of the Board Meeting to consider repurchase of Foreign Currency Debt
Capital/Financing Update
2018-09-28 English
General Announcement::Outcome of Voting of Postal Ballot/E-Voting
Regulatory Filings
2018-09-25 English
General Announcement::Intimation of Board Meeting to consider repurchase of Foreign Currency Debt
Capital/Financing Update
2018-09-25 English
General Announcement::GPL secures marketing authorization in Germany for Seretide Accuhaler
Regulatory Filings
2018-09-10 English
General Announcement::Notice Of 40Th Annual General Meeting To Be Held On September 28, 2018
Proxy Solicitation & Information Statement
2018-09-05 English
General Announcement::Disclosure
Regulatory Filings
2018-08-10 English
General Announcement::Financial Result for quarter ended June 2018
Regulatory Filings
2018-08-10 English
General Announcement::GPLs partner Elite Pharmaceuticals receives US FDA approval
Regulatory Filings
2018-08-07 English
General Announcement::Glenmark Pharmaceuticals and Harbour BioMed Sign Agreement for Greater China to Develop GBR 1302
Regulatory Filings
2018-08-06 English
General Announcement::Board Meeting Intimation
Regulatory Filings
2018-07-30 English
General Announcement::GPL Announces Encouraging Phase 1 Results Supporting Biosimilarity Criteria for GBR 310
Regulatory Filings
2018-07-26 English
General Announcement::GPL receives ANDA approval for Colesevelam Hydrochloride for Oral Suspension
Regulatory Filings
2018-07-17 English
General Announcement::Glenmark Pharmaceuticals Announces Exclusive Licensing Agreement with Seqirus
Regulatory Filings
2018-07-06 English
General Announcement::The US FDA Approves First Supplemental Abbreviated New Drug Application
Regulatory Filings
2018-06-19 English
General Announcement::GPL Announces Poster Presentations on GBR 1302 and GBR 1342 at the 2018 ASCO Annual Meeting
Regulatory Filings
2018-05-28 English
General Announcement::GPL Announces the First New Drug Application Submission for Ryaltris
Regulatory Filings
2018-05-22 English
General Announcement::Glenmark Pharmaceuticals receives ANDA approval for Colesevelam Hydrochloride Tablets, 625 mg
Regulatory Filings
2018-05-21 English
General Announcement::GPL Announces Oral Presentation of New Data on GBR 830
Regulatory Filings
2018-05-18 English
General Announcement::GPL Announces Oral Presentation of New Data on GBR 830
Regulatory Filings
2018-05-18 English
General Announcement::Glenmark Pharmaceuticals receives ANDA approval for Clobetasol Propionate Cream USP, 0.05 Per.
Regulatory Filings
2018-05-11 English
General Announcement::New and Updated Data on GPL GBR 830
Regulatory Filings
2018-05-10 English
General Announcement::GPL receives ANDA approval for Clobetasol Propionate Topical Solution USP, 0.05 Per.
Regulatory Filings
2018-04-20 English
General Announcement::Exclusive Collaboration Agreement with SCD Pharmaceuticals, South Korea
Regulatory Filings
2018-02-22 English
General Announcement::New Data on GBR 830, a First-in-Class, Investigational, Anti-OX40 Monoclonal Antibody
Regulatory Filings
2018-02-19 English